Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy-Reference-Cited by-同舟云学术

Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy

Published:2021-10-01 Issue:10 Volume:7 Page:1544
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Livi Lorenzo¹²,Barletta Giuseppe³,Martella Francesca⁴,Saieva Calogero⁵,Desideri Isacco¹²,Bacci Carlotta⁴,Del Bene Maria Riccarda³,Airoldi Mario⁶,Amoroso Domenico⁷,Coltelli Luigi⁸,Scotti Vieri¹²,Becherini Carlotta¹²,Visani Luca¹²,Salvestrini Viola¹²,Mariotti Matteo¹²,Pedani Fulvia⁶,Bernini Marco⁹,Sanchez Luis⁹,Orzalesi Lorenzo⁹,Nori Jacopo¹⁰,Bianchi Simonetta¹¹,Olivotto Iacopo¹²,Meattini Icro¹²

Affiliation:

1. Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

2. Oncology Department, Careggi University Hospital, Florence, Italy

3. Diagnostic Cardiology, Cardiothoracic, and Vascular Department, Careggi University Hospital, Florence, Italy

4. Breast and Medical Oncology Units, Oncology Department, Azienda USL Toscana Centro, Florence, Italy

5. Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research Prevention and Clinical Network, Florence, Italy

6. Medical Oncology Unit 2, Città della Salute e della Scienza University Hospital, Turin, Italy

7. Medical Oncology Unit, Ospedale Versilia, Lido di Camaiore, Lucca, Italy

8. Medical Oncology Unit, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy

9. Breast Surgery Unit, Careggi University Hospital, Florence, Italy

10. Diagnostic Senology Unit, Careggi University Hospital, Florence, Italy

11. Division of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy

12. Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2783534/jamaoncology_livi_2021_br_210012_1634002362.711.pdf

Reference15 articles.

1. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.;Peto;Lancet,2012

2. Doxorubicin-induced cardiomyopathy.;Singal;N Engl J Med,1998

3. Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?;Ewer;Nat Clin Pract Oncol,2008

4. Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival.;Wang;Breast Cancer Res Treat,2014

5. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.;Plana;Eur Heart J Cardiovasc Imaging,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection strategies for anthracycline cardiotoxicity;Basic Research in Cardiology;2024-09-09

2. Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review;Current Treatment Options in Oncology;2024-07-27

3. Prevention of Anthracyclines and HER2 Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis;Cancers;2024-06-30

4. Prevention of anthracycline and trastuzumab‐induced decline in left ventricular ejection fraction with angiotensin‐converting enzyme inhibitors or angiotensin receptor blocker: a narrative systematic review of randomised controlled trials;Internal Medicine Journal;2024-06-14

5. The protective role of ginsenoside Rg3 in heart diseases and mental disorders;Frontiers in Pharmacology;2024-02-26